Additionally, the putative mechanisms of Cygb expression in cancer were explored by subjecting HNSCC cell lines to hypoxic culture conditions and 5-aza-2-deoxycitidine treatment. This evidence concerns the gene CYGB and head and neck squamous cell carcinoma.